NCT02560025 2020-05-05Phase II Trial of Alisertib With Induction Chemotherapy in High-risk AMLMassachusetts General HospitalPhase 2 Completed42 enrolled 12 charts
NCT01779843 2017-02-17Alisertib for Acute Myeloid LeukemiaMassachusetts General HospitalPhase 1 Completed22 enrolled